| 発表者名 |
タイトル |
発表年度 |
|
Enomoto et al.
|
Case with Metastatic Cutaneous Malignant Melanoma That Developed Vogt–Koyanagi–Harada-like Uveitis Following Pembrolizumab Treatment
|
2021
|
|
Brigell et al.
|
Enhancing Risk Assessment in Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and Structure |
2020 |
|
Grewal et al.
|
A Pilot Study Evaluating the Effects of 670 nm Photobiomodulation in Healthy Ageing and Age-Related Macular Degeneration |
2020 |
|
Ichio et al.
|
Effects of Intravitreal Aflibercept on Retinal Function and Improvement of Macular Edema Associated With Diabetic Retinopathy
|
2020
|
|
Kawai et al.
|
Neuroretinal Dysfunction Revealed by a Flicker Electroretinogram Correlated with Peripheral Nerve Dysfunction and Parameters of Atherosclerosis in Patients with Diabetes
|
2020
|
|
Motz et al.
|
Novel Detection and Restorative Levodopa Treatment for Preclinical Diabetic Retinopathy |
2020 |
|
Kumagai et al.
|
Electroretinograms Before and After Extraction of Large Intraocular Iron Foreign Body
|
2019
|
|
Ozaki et al.
|
Electroretinograms Recorded with Skin Electrodes in Silicone Oil-filled Eyes
|
2019
|
|
Shibuya et al.
|
Electroretinographic Recordings with Skin Electrodes to Assess Effects of Vitrectomy Gas Tamponade on Eyes with Rhegmatogenous Retinal Detachment
|
2019
|
|
Terauchi et al.
|
Retinal Function Determined by Flicker ERGs Before and soon After Intravitreal Injection of Anti-VEGF Agents
|
2019
|
|
Zeng et al.
|
Early Retinal Neurovascular Impairment in Patients with Diabetes Without Clinically Detectable Retinopathy |
2019 |
|
Zeng et al.
|
Retinal Vasculature–function Correlation in Nonproliferative Diabetic Retinopathy |
2019 |
|
Zeng et al.
|
Screening for Diabetic Retinopathy in Diabetic Patients with a Mydriasis-free, Full-field Ficker Electroretinogram Recording Device |
2019 |
|
Degirmenci M.F.K.
|
Role of a Mydriasis-free, Full-field Flicker ERG Device in the Detection of Diabetic Retinopathy |
2018 |
|
Miyata et al.
|
Supernormal Flicker ERGs in Eyes With Central Retinal Vein Occlusion: Clinical Characteristics, Prognosis, and Effects of Anti-VEGF Agent
|
2018
|
|
Al-Otaibi et al.
|
Validity, Usefulness and Cost of RETeval System for Diabetic Retinopathy Screening |
2017 |
|
Fukuo et al.
|
Screening for Diabetic Retinopathy Using New Mydriasis-free, Full-field Flicker ERG Recording Device
|
2016
|
|
Maa et al.
|
A Novel Device for Accurate and Efficient Testing for Vision-threatening Diabetic Retinopathy |
2016 |
|
Yasuda et al.
|
Flicker Electroretinograms Before and After Intravitreal Ranibizumab Injection in Eyes with Central Retinal Vein Occlusion
|
2015
|
